The economic impact of intermittent high-dose intravenous versus oral corticosteroid treatment of juvenile dermatomyositis

Marisa S. Klein-Gitelman, Teresa Waters, Lauren M. Pachman

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Objective. To perform a cost-identification and cost-effectiveness analysis comparing oral corticosteroids (OCS) with high-dose intermittent intravenous corticosteroid (IVCS) regimens in the treatment of juvenile dermatomyositis (JDM). Methods. Children previously diagnosed and treated for JDM (without myositis-specific or myositis-associated autoantibodies) at a single medical center by a single provider were identified. Two treatment protocols were compared: OCS and IVCS. Data on initial disease severity, time to remission, resource use, and costs generated were collected from patient records. Incremental cost-effectiveness ratios (ICE) were constructed. Results. Patients treated with IVCS achieved median remission 2 years earlier at median increased cost of $13,736. The ICE ratio comparing IVCS to OCS is $6,868 per year of disease avoided. Conclusion. This study suggests that, although IVCS treatments are costly, they are cost-effective.

Original languageEnglish (US)
Pages (from-to)360-368
Number of pages9
JournalArthritis Care and Research
Volume13
Issue number6
StatePublished - Dec 1 2000
Externally publishedYes

Fingerprint

Adrenal Cortex Hormones
Economics
Cost-Benefit Analysis
Myositis
Therapeutics
Costs and Cost Analysis
Juvenile dermatomyositis
Clinical Protocols
Health Care Costs
Autoantibodies

All Science Journal Classification (ASJC) codes

  • Rheumatology

Cite this

The economic impact of intermittent high-dose intravenous versus oral corticosteroid treatment of juvenile dermatomyositis. / Klein-Gitelman, Marisa S.; Waters, Teresa; Pachman, Lauren M.

In: Arthritis Care and Research, Vol. 13, No. 6, 01.12.2000, p. 360-368.

Research output: Contribution to journalArticle

@article{1b8def0715cc4c40a2c0ca86187841c7,
title = "The economic impact of intermittent high-dose intravenous versus oral corticosteroid treatment of juvenile dermatomyositis",
abstract = "Objective. To perform a cost-identification and cost-effectiveness analysis comparing oral corticosteroids (OCS) with high-dose intermittent intravenous corticosteroid (IVCS) regimens in the treatment of juvenile dermatomyositis (JDM). Methods. Children previously diagnosed and treated for JDM (without myositis-specific or myositis-associated autoantibodies) at a single medical center by a single provider were identified. Two treatment protocols were compared: OCS and IVCS. Data on initial disease severity, time to remission, resource use, and costs generated were collected from patient records. Incremental cost-effectiveness ratios (ICE) were constructed. Results. Patients treated with IVCS achieved median remission 2 years earlier at median increased cost of $13,736. The ICE ratio comparing IVCS to OCS is $6,868 per year of disease avoided. Conclusion. This study suggests that, although IVCS treatments are costly, they are cost-effective.",
author = "Klein-Gitelman, {Marisa S.} and Teresa Waters and Pachman, {Lauren M.}",
year = "2000",
month = "12",
day = "1",
language = "English (US)",
volume = "13",
pages = "360--368",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - The economic impact of intermittent high-dose intravenous versus oral corticosteroid treatment of juvenile dermatomyositis

AU - Klein-Gitelman, Marisa S.

AU - Waters, Teresa

AU - Pachman, Lauren M.

PY - 2000/12/1

Y1 - 2000/12/1

N2 - Objective. To perform a cost-identification and cost-effectiveness analysis comparing oral corticosteroids (OCS) with high-dose intermittent intravenous corticosteroid (IVCS) regimens in the treatment of juvenile dermatomyositis (JDM). Methods. Children previously diagnosed and treated for JDM (without myositis-specific or myositis-associated autoantibodies) at a single medical center by a single provider were identified. Two treatment protocols were compared: OCS and IVCS. Data on initial disease severity, time to remission, resource use, and costs generated were collected from patient records. Incremental cost-effectiveness ratios (ICE) were constructed. Results. Patients treated with IVCS achieved median remission 2 years earlier at median increased cost of $13,736. The ICE ratio comparing IVCS to OCS is $6,868 per year of disease avoided. Conclusion. This study suggests that, although IVCS treatments are costly, they are cost-effective.

AB - Objective. To perform a cost-identification and cost-effectiveness analysis comparing oral corticosteroids (OCS) with high-dose intermittent intravenous corticosteroid (IVCS) regimens in the treatment of juvenile dermatomyositis (JDM). Methods. Children previously diagnosed and treated for JDM (without myositis-specific or myositis-associated autoantibodies) at a single medical center by a single provider were identified. Two treatment protocols were compared: OCS and IVCS. Data on initial disease severity, time to remission, resource use, and costs generated were collected from patient records. Incremental cost-effectiveness ratios (ICE) were constructed. Results. Patients treated with IVCS achieved median remission 2 years earlier at median increased cost of $13,736. The ICE ratio comparing IVCS to OCS is $6,868 per year of disease avoided. Conclusion. This study suggests that, although IVCS treatments are costly, they are cost-effective.

UR - http://www.scopus.com/inward/record.url?scp=0034529618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034529618&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 360

EP - 368

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 6

ER -